Skip to main content

Advertisement

Log in

Management of Ruptured Brain Arteriovenous Malformations

  • Cardiovascular Disease and Stroke (M Fink and J Safdieh, Section Editors)
  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

Intracranial arteriovenous malformations (AVMs) are a common cause of stroke in younger patients, and often present as intracerebral hemorrhages (ICH), associated with 10 % to 30 % mortality. Patients who present with a hemorrhage from an AVM should be initially stabilized according to acute management guidelines for ICH. The characteristics of a lesion including its size, location in eloquent tissue, and high-risk features will influence risk of rupture, prognosis, as well as help guide management decisions. Given that rupture is associated with an increased risk of 6 % re-rupture in the year following the initial hemorrhage, versus 1 % to 3 % predicted annual risk in non-ruptured lesions only, definitive treatment is encouraged after ICH stabilization. A rest period of 2 to 6 weeks after hemorrhage is recommended before definitive treatment to avoid disrupting friable parenchyma and the hematoma. Treatment may consist of endovascular embolization, surgical resection, radiosurgery, or a combination of these three interventions based on the lesion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Friedlander RM. Clinical practice. Arteriovenous malformations of the brain. N Engl J Med. 2007;356(26):2704–12.

    Article  PubMed  CAS  Google Scholar 

  2. Laakso A, Hernesniemi J. Arteriovenous malformations: epidemiology and clinical presentation. Neurosurg Clin N Am. 2012;23(1):1–6.

    Article  PubMed  Google Scholar 

  3. Steiger H-J, Schmid-Elsaesser R, Muacevic A (2002) Neurosurgery of arteriovenous malformations and fistulas. 473

  4. Ogilvy CS, Stieg PE, Awad I, Brown RD, Kondziolka D, Rosenwasser R, Young WL, Hademenos G, Special Writing Group of the Stroke Council, American Stroke Association. AHA scientific statement: recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke. 2001;32(6):1458–71.

    Article  PubMed  CAS  Google Scholar 

  5. • Aoun SG, Bendok BR, Batjer HH. Acute management of ruptured arteriovenous malformations and dural arteriovenous fistulas. Neurosurg Clin N Am. 2012;23(1):87–103. This article provides an up-to-date, concise review of all relevant studies on the acute management of ruptured lesions.

    Article  PubMed  Google Scholar 

  6. Al-Shahi R, Warlow C. A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults. Brain. 2001;124(Pt 10):1900–26.

    Article  PubMed  CAS  Google Scholar 

  7. • Barr JC, Ogilvy CS. Selection of treatment modalities or observation of arteriovenous malformations. Neurosurg Clin N Am. 2012;23(1):63–75. This article presents concise, evidence-based observations and guidelines for appropriate selection of treatment options for arteriovenous malformations.

    Article  PubMed  Google Scholar 

  8. •• van Beijnum J, van der Worp HB, Buis DR, Al-Shahi Salman R, Kappelle LJ, Rinkel GJE, van der Sprenkel JWB, Vandertop WP, Algra A, Klijn CJM. Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA. 2011;306(18):2011–9. This review provides a comprehensive understanding of global trends and paradigms in the permanent treatment of arteriovenous malformations.

    Article  PubMed  Google Scholar 

  9. Mandybur TI, Nazek M. Cerebral arteriovenous malformations. A detailed morphological and immunohistochemical study using actin. Arch Pathol Lab Med. 1990;114(9):970–3.

    PubMed  CAS  Google Scholar 

  10. Moftakhar P, Hauptman JS, Malkasian D, Martin NA. Cerebral arteriovenous malformations. Part 2: physiology. Neurosurg Focus. 2009;26(5):E11.

    Article  PubMed  Google Scholar 

  11. Graf CJ, Perret GE, Torner JC. Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg. 1983;58(3):331–7.

    Article  PubMed  CAS  Google Scholar 

  12. Stapf C, Mast H, Sciacca RR, Choi JH, Khaw AV, Connolly ES, Pile-Spellman J, Mohr JP. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology. 2006;66(9):1350–5.

    Article  PubMed  CAS  Google Scholar 

  13. Mast H, Young WL, Koennecke HC, Sciacca RR, Osipov A, Pile-Spellman J, Hacein-Bey L, Duong H, Stein BM, Mohr JP. Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet. 1997;350(9084):1065–8.

    Article  PubMed  CAS  Google Scholar 

  14. Forster DM, Steiner L, Håkanson S. Arteriovenous malformations of the brain. A long-term clinical study. J Neurosurg. 1972;37(5):562–70.

    Article  PubMed  CAS  Google Scholar 

  15. van Beijnum J, Lovelock CE, Cordonnier C, Rothwell PM, Klijn CJM, Al-Shahi Salman R, on behalf of the SIVMS Steering Committee and the Oxford Vascular Study. Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies. Brain. 2008;132(2):537–43.

    Article  PubMed  Google Scholar 

  16. Diringer MN. Intracerebral hemorrhage: pathophysiology and management. Crit Care Med. 1993;21(10):1591–603.

    Article  PubMed  CAS  Google Scholar 

  17. Abdullah AR, Smith EE, Biddinger PD, Kalenderian D, Schwamm LH. Advance hospital notification by EMS in acute stroke is associated with shorter door-to-computed tomography time and increased likelihood of administration of tissue-plasminogen activator. Prehosp Emerg Care. 2008;12(4):426–31.

    Article  PubMed  Google Scholar 

  18. Morgenstern LB, Hemphill JC, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41(9):2108–29.

    Article  PubMed  Google Scholar 

  19. Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med. 2001;29(3):635–40.

    Article  PubMed  CAS  Google Scholar 

  20. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation. 2007;116(16):e391–413.

    Article  PubMed  Google Scholar 

  21. Schutz H, Bodeker R, Damian M, Krack P, Dorndorf W. Age-related spontaneous intracerebral hematoma in a German community. Stroke. 1990;21:1412–8.

    Article  PubMed  CAS  Google Scholar 

  22. Sturgeon JD, Folsom AR, Longstreth WT, Shahar E, Rosamond WD, Cushman M. Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke. 2007;38(10):2718–25.

    Article  PubMed  Google Scholar 

  23. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344(19):1450–60.

    Article  PubMed  CAS  Google Scholar 

  24. Nüssel F, Wegmüller H, Huber P. Comparison of magnetic resonance angiography, magnetic resonance imaging and conventional angiography in cerebral arteriovenous malformation. Neuroradiology. 1991;33(1):56–61.

    Article  PubMed  Google Scholar 

  25. Anzalone N, Scomazzoni F, Strada L, Patay Z, Scotti G. Intracranial vascular malformations. Eur Radiol. 1998;8(5):685–90.

    Article  PubMed  CAS  Google Scholar 

  26. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T, FAST trial investigators. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358(20):2127–37.

    Article  PubMed  CAS  Google Scholar 

  27. • Adeoye O, Broderick JP. Advances in the management of intracerebral hemorrhage. Nat Rev Neurol. 2010;6(11):593–601. This article eloquently summarizes relevant literature on advances in treatments for intracerebral hemorrhage and provides an important framework for future adoption of new treatment options.

    Article  PubMed  CAS  Google Scholar 

  28. Zhang Y, Reilly KH, Tong W, Xu T, Chen J, Bazzano LA, Qiao D, Ju Z, Chen C-S, He J. Blood pressure and clinical outcome among patients with acute stroke in Inner Mongolia, China. J Hypertens. 2008;26(7):1446–52.

    Article  PubMed  CAS  Google Scholar 

  29. Anderson CS, Huang Y, Arima H, et al. Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT). Stroke. 2010;41(2):307–12.

    Article  PubMed  Google Scholar 

  30. Qureshi AI, Palesch YY. Antihypertensive treatment of acute cerebral hemorrhage (ATACH) II: design, methods, and rationale. Neurocritical care. 2011. doi:10.1007/s12028-011-9538-3.

  31. Fogelholm R, Murros K, Rissanen A, Avikainen S. Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study. J Neurol Neurosurg Psychiatr. 2005;76(3):349–53.

    Article  PubMed  CAS  Google Scholar 

  32. Schwarz S, Häfner K, Aschoff A, Schwab S. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology. 2000;54(2):354–61.

    Article  PubMed  CAS  Google Scholar 

  33. Kollmar R, Juettler E, Huttner HB, Dörfler A, Staykov D, Kallmuenzer B, Schmutzhard E, Schwab S, Broessner G, for the CINCH investigators. Cooling in intracerebral hemorrhage (CINCH) trial: protocol of a randomized German-Austrian clinical trial. Int J Stroke. 2012;7(2):168–72.

    Article  PubMed  Google Scholar 

  34. Bladin CF, Alexandrov AV, Bellavance A, Bornstein N, Chambers B, Coté R, Lebrun L, Pirisi A, Norris JW. Seizures after stroke: a prospective multicenter study. Arch Neurol. 2000;57(11):1617–22.

    Article  PubMed  CAS  Google Scholar 

  35. Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65(4):476–83.

    Article  PubMed  CAS  Google Scholar 

  36. Kuhmonen J, Piippo A, Väärt K, Karatas A, Ishii K, Winkler P, Niemelä M, Porras M, Hernesniemi J. Early surgery for ruptured cerebral arteriovenous malformations. Acta Neurochir Suppl. 2005;94:111–4.

    Article  PubMed  CAS  Google Scholar 

  37. Brown RD. Simple risk predictions for arteriovenous malformation hemorrhage. Neurosurgery. 2000;46(4):1024.

    PubMed  Google Scholar 

  38. Mohr JP, Moskowitz AJ, Stapf C, et al. The ARUBA trial: current status, future hopes. Stroke. 2010;41(8):e537–40.

    Article  PubMed  CAS  Google Scholar 

  39. Brown RD, Flemming KD, Meyer FB, Cloft HJ, Pollock BE, Link ML. Natural history, evaluation, and management of intracranial vascular malformations. Mayo Clin Proc. 2005;80(2):269–81.

    Article  PubMed  Google Scholar 

  40. Hartmann A, Pile-Spellman J, Stapf C, Sciacca RR, Faulstich A, Mohr JP, Schumacher HC, Mast H. Risk of endovascular treatment of brain arteriovenous malformations. Stroke. 2002;33(7):1816–20.

    Article  PubMed  CAS  Google Scholar 

  41. Pikus HJ, Beach ML, Harbaugh RE. Microsurgical treatment of arteriovenous malformations: analysis and comparison with stereotactic radiosurgery. J Neurosurg. 1998;88(4):641–6.

    Article  PubMed  CAS  Google Scholar 

  42. Maruyama K, Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD. Stereotactic radiosurgery for brainstem arteriovenous malformations: factors affecting outcome. J Neurosurg. 2004;100(3):407–13.

    Article  PubMed  Google Scholar 

  43. Maruyama K, Koga T, Shin M, Igaki H, Tago M, Saito N. Optimal timing for Gamma Knife surgery after hemorrhage from brain arteriovenous malformations. J Neurosurg. 2008;109(Suppl):73–6.

    PubMed  Google Scholar 

  44. Maruyama K, Kawahara N, Shin M, Tago M, Kishimoto J, Kurita H, Kawamoto S, Morita A, Kirino T. The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med. 2005;352(2):146–53.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by a grant from the Doris Duke Charitable Foundation to Columbia University to fund Clinical Research Fellow KAV. Source of Funding: Department of Neurological Surgery, Doris Duke Charitable Foundation

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Brad E. Zacharia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zacharia, B.E., Vaughan, K.A., Jacoby, A. et al. Management of Ruptured Brain Arteriovenous Malformations. Curr Atheroscler Rep 14, 335–342 (2012). https://doi.org/10.1007/s11883-012-0257-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-012-0257-9

Keywords

Navigation